Optimal Design for Evaluation of Renal Denervation Devices: US Academia View - David Kandzari, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Japan-US Synergies: Optimal Design for Evaluation of Renal Denervation Devices

Add this Moment to your Passport

Learn from this moment and keep it forever.
No longer available for purchase

Preview

Summary

Optimal Design for Evaluation of Renal Denervation Devices: US Academia View presented by David Kandzari, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
No longer available for purchase

Target Audience

  • Interventional Cardiologists
  • Clinical Trial Investigators
  • Medical Device Professionals

Session Name: Japan-US Synergies: Optimal Design for Evaluation of Renal Denervation Devices

Track: Technology & Innovation

Learning Objectives

  • Updates on regulatory harmonisation and clinical trial design in the US & Japan

Other Components in this Moment

Overview
Lessons Learned from SYMPLICITY HTN-3 Results for Further Clinical Trials - Sidney Cohen
Optimal Design for Evaluation of Renal Denervation Devices: US Academia View - David Kandzari, MD, FSCAI
Optimal Design for Evaluation of Renal Denervation Devices: Japan Academia View - Takafumi Ueno, MD, PhD
Sham Operation and Other Points to Consider for Evaluation of Renal Denervation Devices: Japan Academia View - Koji Ikeda, PhD
Loading Simple Education